321 related articles for article (PubMed ID: 9689572)
1. Pharmacoresistance: an emerging clinical problem.
Carosi G
J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):9-14. PubMed ID: 9689572
[No Abstract] [Full Text] [Related]
2. Viral resistance: a major challenge in managing HIV disease.
Boucher CA; Reedijk M
J Biol Regul Homeost Agents; 1995; 9(3):91-4. PubMed ID: 8782014
[No Abstract] [Full Text] [Related]
3. [Molecular bases in the search for drugs for treating AIDS. Achievements and possible prospects].
Kraevskiĭ AA
Mol Biol (Mosk); 1999; 33(3):343-52. PubMed ID: 10519109
[No Abstract] [Full Text] [Related]
4. The daunting challenge of keeping HIV suppressed.
Cohen J
Science; 1997 Jul; 277(5322):32-3. PubMed ID: 9229768
[No Abstract] [Full Text] [Related]
5. Current clinical treatments of AIDS.
Murphy EM; Jimenez HR; Smith SM
Adv Pharmacol; 2008; 56():27-73. PubMed ID: 18086408
[No Abstract] [Full Text] [Related]
6. Antiretroviral update: recent advances expand options for patients with HIV.
Santhanam H; Goins M
Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
[No Abstract] [Full Text] [Related]
7. Salvage therapy for patients failing their current antiretroviral regimen.
Albrecht MA
AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220
[No Abstract] [Full Text] [Related]
8. HIV resistance testing proves its value.
Proj Inf Perspect; 1999 Sep; (28):14. PubMed ID: 11367356
[TBL] [Abstract][Full Text] [Related]
9. [Human immunodeficiency virus and antiretroviral therapy resistance].
Quirós E; Torti C; Carosi G
Enferm Infecc Microbiol Clin; 2000 May; 18(5):234-7. PubMed ID: 10974768
[No Abstract] [Full Text] [Related]
10. Current insights into reverse transcriptase inhibitor-associated resistance.
Wainberg MA; White AJ
Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474
[No Abstract] [Full Text] [Related]
11. [New trends in HIV].
Volkert R
Dtsch Med Wochenschr; 1998 Sep; 123(38):A7. PubMed ID: 9787287
[No Abstract] [Full Text] [Related]
12. [Can HIV/AIDS be healed with new therapies?].
Battegay M
Praxis (Bern 1994); 1997 May; 86(22):931-2. PubMed ID: 9289789
[No Abstract] [Full Text] [Related]
13. [AIDS: the myth of Sisyphus].
Jaubert D
Med Trop (Mars); 1999; 59(1):31-2. PubMed ID: 10472577
[No Abstract] [Full Text] [Related]
14. [Drug resistance in antiretroviral therapy of HIV infection].
Oette M; Häussinger D
Med Klin (Munich); 2003 Dec; 98(12):692-9. PubMed ID: 14685670
[TBL] [Abstract][Full Text] [Related]
15. Therapies. Confronting the limits of success.
Cohen J
Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
[No Abstract] [Full Text] [Related]
16. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
[No Abstract] [Full Text] [Related]
17. Clinical utility of resistance testing.
Stebbing J; Gazzard BG
J HIV Ther; 2002 Nov; 7(4):75-9. PubMed ID: 12733604
[No Abstract] [Full Text] [Related]
18. Revisiting the concept of a genetic barrier to resistance.
Rusconi S
J HIV Ther; 2006 Dec; 11(4):81-3. PubMed ID: 17578211
[No Abstract] [Full Text] [Related]
19. [HIV infection. Virus resistance: development and prevention].
Link R; Miller V; Fätkenheuer G; Manegold C; Harrer T
Med Monatsschr Pharm; 1999 Mar; 22(3):86-8. PubMed ID: 10223868
[No Abstract] [Full Text] [Related]
20. Combination therapy in the management of HIV infection.
Vella S; Franca Pirillo M
Methods Find Exp Clin Pharmacol; 1996; 18 Suppl C():23-6. PubMed ID: 9003571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
